M. Oh

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 324 citations

Medicine, Hematology, Hemostasis +12

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

Peter W. Collins, Sven Björkman, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2009 · 186 citations

Medicine, Hematology, Pharmacokinetics +16

Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring

Sven Björkman, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2010 · 123 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Association of peak factor <scp>VIII</scp> levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic‐guided prophylaxis

Leonard A. Valentino, Steven W. Pipe, P. Collins et al. · Haemophilia · 2016 · 62 citations · Full text

Medicine, Hematology, Pharmacokinetics +15

Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials

Kathelijn Fischer, Peter W. Collins, Sven Björkman et al. · Haemophilia · 2011 · 55 citations

Medicine, Hematology, Pediatrics +14